Milestone Historical Cash Flow
| MIST Stock | USD 1.63 0.12 6.86% |
Analysis of Milestone Pharmaceuticals cash flow over time is an excellent tool to project Milestone Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Borrowings of 0.0 or Stock Based Compensation of 11.5 M as it is a great indicator of Milestone Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Milestone Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Milestone Pharmaceuticals is a good buy for the upcoming year.
Milestone |
About Milestone Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Milestone balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Milestone's non-liquid assets can be easily converted into cash.
Milestone Pharmaceuticals Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Milestone Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Milestone Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more information on how to buy Milestone Stock please use our How to Invest in Milestone Pharmaceuticals guide.At this time, Milestone Pharmaceuticals' Change To Inventory is comparatively stable compared to the past year. Change In Cash is likely to gain to about 5.8 M in 2025, whereas Free Cash Flow is likely to drop (44 M) in 2025.
Milestone Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Milestone Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Milestone Pharmaceuticals cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Sale Purchase Of Stock | 80.5M | 85.4M | 48.5M | 121K | 108.9K | 103.5K | |
| Change To Inventory | 169K | 112K | (465K) | 730K | 839.5K | 881.5K | |
| Investments | (70M) | 70M | (57.1M) | (25.9M) | (23.3M) | (22.2M) | |
| Change In Cash | (47.5M) | 41.8M | (106.5M) | 6.1M | 5.5M | 5.8M | |
| Stock Based Compensation | 4.9M | 7.3M | 9.0M | 9.5M | 11.0M | 11.5M | |
| Free Cash Flow | (50.7M) | (33.2M) | (52.7M) | (46.5M) | (41.9M) | (44.0M) | |
| Change In Working Capital | (5.8M) | 2.3M | (3.3M) | 1.2M | 1.1M | 1.2M | |
| Begin Period Cash Flow | 119.8M | 72.3M | 114.1M | 7.6M | 8.8M | 8.3M | |
| Total Cashflows From Investing Activities | (384K) | (70M) | 70M | (57.1M) | (51.4M) | (48.8M) | |
| Other Cashflows From Financing Activities | 48.3M | 5.1M | 458K | (2.2M) | (2.0M) | (1.9M) | |
| Depreciation | 97K | 93K | 89K | 92K | 105.8K | 67.1K | |
| Capital Expenditures | 97K | 0.0 | 272K | 112K | 128.8K | 146.9K | |
| Total Cash From Operating Activities | (50.7M) | (33.2M) | (52.5M) | (46.4M) | (41.8M) | (43.9M) | |
| Change To Account Receivables | (112K) | 465K | (730K) | (2.6M) | (2.4M) | (2.3M) | |
| Change To Operating Activities | (735K) | (3.8M) | 1.5M | (1.6M) | (1.4M) | (1.5M) | |
| Net Income | (50.0M) | (42.9M) | (58.4M) | (59.7M) | (53.7M) | (56.4M) | |
| Total Cash From Financing Activities | 73.2M | 5.1M | 3.1M | 47.8M | 43.0M | 37.2M | |
| End Period Cash Flow | 72.3M | 114.1M | 7.6M | 13.8M | 12.4M | 11.8M | |
| Other Cashflows From Investing Activities | 29K | (70M) | 70M | (86.1M) | (77.5M) | (73.6M) | |
| Change To Netincome | 633K | 993K | 4.7M | 7.3M | 8.4M | 8.8M | |
| Change To Liabilities | 3.5M | (2.1M) | 637K | (907K) | (816.3K) | (775.5K) | |
| Other Non Cash Items | 5.5M | 7.3M | 44K | 2.4M | 2.8M | 2.9M | |
| Issuance Of Capital Stock | 24.9M | 0.0 | 2.6M | (14K) | (12.6K) | (12.0K) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Milestone Stock Analysis
When running Milestone Pharmaceuticals' price analysis, check to measure Milestone Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Pharmaceuticals is operating at the current time. Most of Milestone Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Milestone Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Pharmaceuticals' price. Additionally, you may evaluate how the addition of Milestone Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.